Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

The expression of phosphorylated Akt (pAkt) and phosphorylated extracellular-regulated kinase 1/2 (pErk1/2) proteins may result in breast cancer progression and drug resistance in vitro, however, compelling evidence regarding the clinical significance of pAkt and pErk1/2 in early-stage breast cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: LIU, WENJUAN, ZHANG, LINGYUN, SHI, JING, LIU, YUNPENG, ZHOU, LIZHONG, HOU, KEZUO, QU, XIUJUAN, TENG, YUEE
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356398/
https://ncbi.nlm.nih.gov/pubmed/25789027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.2965
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados